Leflore, S <br/><br/>
A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections.  [electronic resource] 

 -  Drug safety  Aug 2000 
 - 131-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0114-5916 
<br/><br/><label>Standard No.: </label>10.2165/00002018-200023020-00004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyclovir--adverse effects<br/>Antiviral Agents--adverse effects<br/>Herpes Simplex--drug therapy<br/>Humans<br/>Immunocompromised Host<br/>Risk